Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma

Lymphoepithelioma-like hepatocellular carcinoma (LEL-HCC) is a very rare neoplasm, with distinct epidemiologic, morphologic and clinical characteristics. Molecular mechanistic insight into the pathogenesis of this carcinoma suggests a pivotal role for the host immune system in the proliferation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermel, David J., Du, Emma Z., Lin, Ray, Frenette, Catherine T., Sigal, Darren S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111110/
https://www.ncbi.nlm.nih.gov/pubmed/34007809
http://dx.doi.org/10.14218/JCTH.2020.00094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111110/
https://www.ncbi.nlm.nih.gov/pubmed/34007809
http://dx.doi.org/10.14218/JCTH.2020.00094

Ejemplares similares